Monica M. Bertagnolli, MD, FACS, FASCO, and W. Kimryn Rathmell, MD, PhD, have stepped down as directors of the NIH and NCI as ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

Hematology-Oncology Associates of CNY has announced that Jennifer Pichoske will become its chief executive officer effective ...

You may get radiation therapy at one or more of these locations. Your radiation oncology team will tell you where to go. Our centers feature state-of-the-art equipment so your doctor and care team can ...

( MENAFN - GlobeNewsWire - Nasdaq) Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Bayer AG 2024" report has been added to ResearchAndMarkets.com's offering.

Postmenopausal hormone therapy (HT) did not significantly increase the risk of glioma, leaving unresolved the reason for the ...

Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer, effective Feb. 15. She succeeds longtime CEO Maryann Roefaro, who is retiring from the position ...

About 100 students from Apollo High School will raise money for cancer treatment Sunday, when the students hold their annual DanceBlue Marathon from 4 p.m. to midnight at AHS. The event is a ...

Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...

Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...

Delaware-based Incyte Corporation (INCY) focuses on the discovery, development, and commercialization of therapeutics for ...

Individualized treatments for cancer show great promise, and three KC-area providers are dialing up their offerings.